US Equities Analysis

WELL — Welltower

WELL Price Chart FCF Yield Dividend Yield Price / Earnings Price / Book EV / EBITDA EV / NOPAT Consensus EPS Broker Sentiment EBITDA Margin EBIT Margin ROIC & ROE Capital Turnover Capex & WC / Sales Net Debt / Equity Price and 100d MA Relative to Index Relative to MSCI


1. Industry Fundamentals

1.1 Cyclicality

The company operates in a cyclical industry sensitive to macroeconomic conditions. Revenue and earnings tend to correlate with broader economic cycles, with periods of expansion driving growth and contractions creating headwinds. Current market capitalisation: 149.2B.

1.2 Competition

The industry is moderately competitive with established players and meaningful barriers to entry. Beta of 0.78 suggests moderate market sensitivity. Competitive advantages stem from brand, scale, or regulatory moats.

1.3 Technology

Key technology drivers include digital transformation, operational efficiency, automation. Companies that invest in R&D and adopt new technologies tend to gain market share. The pace of technological change creates both opportunities for innovation and risks of disruption.


2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 18.04%
Profit Margins 11.96%
Return on Equity 3.67%
Return on Assets 0.74%
Free Float 0.7B
Dividend Yield 1.30%
Short Int % Utilisation 2.86%

2.2 Growth

Metric Value
Revenue Growth 38.3%
Free Cash Flow 2.6B
EBITDA 55.41 (Ratio)
Enterprise Value 165.62B
EV/Revenue 14.07
EV/EBITDA 55.41

Revenue growth of 38.3% places the company in a high-growth category.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.) 24.93%
Risk / Std Dev (Ann.) 23.83%
Sharpe Ratio (rf=4.5%) 0.86
Beta 0.78

2.5 Valuation

Metric Value
P/E (Forward) 62.9
Price/Book 3.60
EV/Revenue 14.07
EV/EBITDA 55.41
Enterprise Value / NOPAT 72.03
FCF Yield (%) 1.69%
Price / Earnings 105.15
Price / Book 3.60
Enterprise Value / EBITDA 56.91

Forward P/E of 63x is elevated, suggesting the market is pricing in significant future growth or a turn-around.

2.6 Return Outlook

The stock’s historical risk-return profile shows an annualised expected return of 24.9% with annualised volatility of 23.8%, yielding a Sharpe ratio of 0.86 (rf=4.5%). The risk-adjusted return is attractive relative to the risk-free rate. With a beta of 0.8, the stock is less volatile than the market, offering relative downside protection.


us-equitystockequitywellreal-estatehealth-care-reitsnasdaq